Health Condition 1: null- Facial deformity
Conditions
Interventions
Intervention1: Intravenous Clonidine: loading dose of 2-5 µg/kg clonidine over 20 min, followed by 0.3-2 µg/kg/h
Control Intervention1: Intravenouus dexmeditomidine: loading dose of 1µg/kg dexmedetom
Sponsors
Department of Anaesthesiology
Eligibility
Inclusion criteria
Inclusion criteria: American society of anesthesiologists physical status 1 Elective orthognatic surgery
Exclusion criteria
Exclusion criteria: Associated comorbidities Known allergy or contraindication to the use of any of the drugs Patients requiring awake intubation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative vital parameters ( Heart rate, systolic blood pressure, diastolic blood pessure, mean arterial pressure) Timepoint: every 15 minutes till end of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Total amount of study drug required Total amount of rescue analgesia Total Blood loss Need for blood transfusion Duration of surgery Quality of surgical field Adverse effects Timepoint: End of surgery to 6 hours post operatively | — |
Countries
India
Contacts
Public ContactDevalina Goswami
Centre for Dental Education and Research Centre, All India Institute of Medical Sciences, New Delhi
Outcome results
None listed